75
Participants
Start Date
April 11, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
EDG-7500
Liquid suspension formulation of EDG-7500
EDG-7500
Solid oral formulation of EDG-7500
RECRUITING
NYU Langone Health Medical Center - HCM Program Office (Study open to existing NYU patients only), New York
RECRUITING
North Shore University Hospital, Manhasset
RECRUITING
Hospital of the University of Pennsylvania (University of Pennsylvania School of Medicine), Philadelphia
RECRUITING
University of Virginia Heart and Vascular Center Fontaine, Charlottesville
RECRUITING
Sanger Heart and Vascular Institute, Charlotte
RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
James A. Haley Veterans' Hospital, Tampa
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
The Lindner Research Center at Christ Hospital, Cincinnati
RECRUITING
Saint Luke's Hospital of Kansas City, Kansas City
RECRUITING
University of California, San Francisco, San Francisco
RECRUITING
Stanford University Hospital / Stanford Health Care, Stanford
RECRUITING
Oregon Health & Science University (OHSU), Portland
RECRUITING
Virginia Mason Medical Center, Seattle
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Brigham and Womens Hospital, Boston
RECRUITING
Lahey Hospital and Medical Center, Burlington
RECRUITING
Morristown Medical Center (Atlantic Health System), Morristown
Lead Sponsor
Edgewise Therapeutics, Inc.
INDUSTRY